107 related articles for article (PubMed ID: 21427916)
1. [Prolonged therapy with proton pump inhibitors: balance of benefits and risks].
Lazebnik LB; Bordin DS; Masharova AA
Eksp Klin Gastroenterol; 2010; (9):3-8. PubMed ID: 21427916
[No Abstract] [Full Text] [Related]
2. [Influence of long-term intake of proton pump inhibitors on gastric mucosa and neuroendocrine system of gastric secretion regulation in patients with acid-dependent diseases].
Rapoport SI; Khutsishvili MB; Rasulov MI; Trubitsina IE; Raĭkhlin NT
Ter Arkh; 2008; 80(2):86-9. PubMed ID: 18372605
[No Abstract] [Full Text] [Related]
3. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
[TBL] [Abstract][Full Text] [Related]
4. Is there a dark side to long-term proton pump inhibitor therapy?
Nealis TB; Howden CW
Am J Ther; 2008; 15(6):536-42. PubMed ID: 19127138
[TBL] [Abstract][Full Text] [Related]
5. Long-term acid inhibition: benefits and harms.
Tepeš B
Dig Dis; 2011; 29(5):476-81. PubMed ID: 22095013
[TBL] [Abstract][Full Text] [Related]
6. Gastric secretion.
Schubert ML
Curr Opin Gastroenterol; 2010 Nov; 26(6):598-603. PubMed ID: 20838342
[TBL] [Abstract][Full Text] [Related]
7. Immediate-release oral proton pump inhibitors: Panacea or a flash in the pan?
Chan FK
J Gastroenterol Hepatol; 2010 Jan; 25(1):6-7. PubMed ID: 20136970
[No Abstract] [Full Text] [Related]
8. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
Weigt J; Kandulski A; Büsch F; Malfertheiner P
Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
[TBL] [Abstract][Full Text] [Related]
9. Stopping proton pump inhibitor use may cause heartburn.
Mayo Clin Health Lett; 2010 Jan; 28(1):4. PubMed ID: 20148484
[No Abstract] [Full Text] [Related]
10. Proton pump inhibitors and fractures? Beware long-term use.
Prescrire Int; 2009 Oct; 18(103):216. PubMed ID: 19885973
[No Abstract] [Full Text] [Related]
11. Consequences of long-term proton pump blockade: insights from studies of patients with gastrinomas.
Jensen RT
Basic Clin Pharmacol Toxicol; 2006 Jan; 98(1):4-19. PubMed ID: 16433886
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and the risk of colorectal cancer: a meta-analysis.
Chen S; Song X; Gao X; Li M; Chen Z; He Y; Zhan W
J Clin Gastroenterol; 2011 Feb; 45(2):177. PubMed ID: 20697292
[No Abstract] [Full Text] [Related]
13. [Does long-term use of proton pump inhibitors promote premalignant lesions of the gastric mucosa?].
Ruetsch R; Juillerat P; Flatz A; von Elm E
Praxis (Bern 1994); 2016 Feb; 105(4):221-2. PubMed ID: 26886699
[No Abstract] [Full Text] [Related]
14. [Does dual antiplatelet therapy always require gastroprotection? Gastroprotection with proton pump inhibitors is advisable for all patients who need dual antiplatelet therapy].
Morini S; Zullo A
G Ital Cardiol (Rome); 2010 Jun; 11(6):488-92; discussion 492. PubMed ID: 20922875
[No Abstract] [Full Text] [Related]
15. [Long-term therapy of acid-dependent diseases with proton pump inhibitors and risk of colorectal cancer (literature review)].
Bordin DS; Masharova AA; Lazebnik LB
Eksp Klin Gastroenterol; 2008; (4):36-8. PubMed ID: 19145902
[No Abstract] [Full Text] [Related]
16. Clinical trial: inhibitory effect of revaprazan on gastric acid secretion in healthy male subjects.
Kim HK; Park SH; Cheung DY; Cho YS; Kim JI; Kim SS; Chae HS; Kim JK; Chung IS
J Gastroenterol Hepatol; 2010 Oct; 25(10):1618-25. PubMed ID: 20880169
[TBL] [Abstract][Full Text] [Related]
17. Control of gastric acid secretion in health and disease.
Schubert ML; Peura DA
Gastroenterology; 2008 Jun; 134(7):1842-60. PubMed ID: 18474247
[TBL] [Abstract][Full Text] [Related]
18. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
Vasil'ev IuV; Beliaeva VS
Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
[No Abstract] [Full Text] [Related]
19. Evidence that proton-pump inhibitor therapy induces the symptoms it is used to treat.
McColl KE; Gillen D
Gastroenterology; 2009 Jul; 137(1):20-2. PubMed ID: 19482105
[No Abstract] [Full Text] [Related]
20. Addicted to acid suppression.
Hanauer SB
Nat Rev Gastroenterol Hepatol; 2009 Sep; 6(9):497. PubMed ID: 19713979
[No Abstract] [Full Text] [Related]
[Next] [New Search]
